Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 44 studies | 32% ± 12% | |
fibroblast | 30 studies | 26% ± 6% | |
astrocyte | 21 studies | 40% ± 17% | |
smooth muscle cell | 17 studies | 24% ± 6% | |
pericyte | 17 studies | 25% ± 8% | |
endothelial cell of lymphatic vessel | 16 studies | 32% ± 11% | |
ciliated cell | 16 studies | 28% ± 11% | |
endothelial cell of vascular tree | 15 studies | 28% ± 12% | |
oligodendrocyte precursor cell | 14 studies | 37% ± 19% | |
basal cell | 12 studies | 34% ± 21% | |
connective tissue cell | 11 studies | 28% ± 8% | |
vein endothelial cell | 11 studies | 35% ± 14% | |
myofibroblast cell | 10 studies | 27% ± 10% | |
endothelial cell of artery | 10 studies | 22% ± 5% | |
adipocyte | 10 studies | 31% ± 13% | |
oligodendrocyte | 10 studies | 30% ± 12% | |
GABAergic neuron | 9 studies | 41% ± 19% | |
glutamatergic neuron | 9 studies | 51% ± 22% | |
microglial cell | 9 studies | 34% ± 18% | |
epithelial cell | 9 studies | 46% ± 21% | |
type I pneumocyte | 9 studies | 31% ± 12% | |
club cell | 8 studies | 25% ± 9% | |
capillary endothelial cell | 8 studies | 27% ± 5% | |
macrophage | 8 studies | 30% ± 16% | |
neuron | 7 studies | 39% ± 19% | |
retinal cone cell | 7 studies | 40% ± 9% | |
interneuron | 6 studies | 44% ± 20% | |
type II pneumocyte | 6 studies | 25% ± 8% | |
mesothelial cell | 6 studies | 34% ± 14% | |
Mueller cell | 6 studies | 24% ± 5% | |
ionocyte | 5 studies | 37% ± 10% | |
secretory cell | 5 studies | 28% ± 10% | |
renal alpha-intercalated cell | 5 studies | 22% ± 6% | |
abnormal cell | 5 studies | 25% ± 9% | |
retinal rod cell | 5 studies | 22% ± 4% | |
cardiac muscle cell | 5 studies | 23% ± 4% | |
lymphocyte | 5 studies | 26% ± 6% | |
goblet cell | 5 studies | 34% ± 20% | |
respiratory goblet cell | 4 studies | 34% ± 15% | |
podocyte | 4 studies | 35% ± 7% | |
progenitor cell | 4 studies | 26% ± 4% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 20% ± 5% | |
granule cell | 4 studies | 27% ± 7% | |
natural killer cell | 4 studies | 16% ± 2% | |
retinal pigment epithelial cell | 4 studies | 40% ± 9% | |
myeloid cell | 4 studies | 19% ± 3% | |
T cell | 4 studies | 20% ± 4% | |
glomerular endothelial cell | 3 studies | 35% ± 6% | |
B cell | 3 studies | 17% ± 2% | |
GABAergic interneuron | 3 studies | 28% ± 2% | |
glial cell | 3 studies | 36% ± 7% | |
squamous epithelial cell | 3 studies | 33% ± 21% | |
brush cell | 3 studies | 34% ± 7% | |
amacrine cell | 3 studies | 18% ± 4% | |
retina horizontal cell | 3 studies | 19% ± 2% | |
hepatocyte | 3 studies | 29% ± 14% | |
muscle cell | 3 studies | 36% ± 12% | |
dendritic cell | 3 studies | 20% ± 5% | |
ependymal cell | 3 studies | 54% ± 15% | |
intestinal crypt stem cell | 3 studies | 17% ± 1% | |
adventitial cell | 3 studies | 20% ± 2% | |
chondrocyte | 3 studies | 41% ± 11% | |
Schwann cell | 3 studies | 35% ± 13% | |
transit amplifying cell | 3 studies | 40% ± 35% | |
mast cell | 3 studies | 23% ± 5% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 4% | |
mucus secreting cell | 3 studies | 36% ± 13% | |
enteroendocrine cell | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 5021.79 | 180 / 180 | 100% | 31.34 | 429 / 430 |
esophagus | 100% | 2111.99 | 1445 / 1445 | 99% | 20.38 | 182 / 183 |
intestine | 100% | 1992.11 | 966 / 966 | 99% | 19.82 | 521 / 527 |
stomach | 100% | 1536.92 | 358 / 359 | 99% | 21.43 | 283 / 286 |
lung | 100% | 2314.50 | 577 / 578 | 98% | 19.58 | 1130 / 1155 |
breast | 100% | 2858.93 | 459 / 459 | 97% | 27.07 | 1085 / 1118 |
bladder | 100% | 2388.29 | 21 / 21 | 96% | 18.59 | 483 / 504 |
skin | 100% | 2540.52 | 1809 / 1809 | 95% | 21.43 | 448 / 472 |
brain | 96% | 1192.33 | 2544 / 2642 | 99% | 25.68 | 695 / 705 |
pancreas | 98% | 1069.29 | 323 / 328 | 96% | 20.36 | 170 / 178 |
kidney | 100% | 1996.66 | 89 / 89 | 94% | 20.36 | 844 / 901 |
prostate | 100% | 2003.27 | 245 / 245 | 93% | 14.71 | 467 / 502 |
thymus | 100% | 3214.54 | 653 / 653 | 93% | 21.58 | 560 / 605 |
uterus | 100% | 3839.99 | 170 / 170 | 90% | 17.09 | 412 / 459 |
adrenal gland | 100% | 2847.58 | 258 / 258 | 67% | 6.60 | 154 / 230 |
liver | 68% | 429.75 | 153 / 226 | 53% | 5.00 | 217 / 406 |
adipose | 100% | 2606.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4191.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1313.46 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 1275.26 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 12.92 | 76 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 17.87 | 41 / 45 |
muscle | 87% | 776.50 | 700 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 8.53 | 25 / 29 |
peripheral blood | 44% | 730.39 | 410 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060044 | Biological process | negative regulation of cardiac muscle cell proliferation |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0035331 | Biological process | negative regulation of hippo signaling |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005634 | Cellular component | nucleus |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VGLL4 |
Protein name | Vestigial like family member 4 Vestigial like 4 (Drosophila), isoform CRA_d (Vestigial like family member 4) Vestigial like 4 (Drosophila), isoform CRA_b (Vestigial like family member 4) Transcription cofactor vestigial-like protein 4 (Vgl-4) Vestigial-like 4 Vestigial like 4 (Drosophila), isoform CRA_c (Vestigial like family member 4) |
Synonyms | KIAA0121 hCG_1777277 |
Description | FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . |
Accessions | A0A0A6YYI5 G5E9M9 Q14135 ENST00000419541.4 G5E9M7 ENST00000417206.6 ENST00000623028.1 ENST00000430365.7 ENST00000418000.5 ENST00000445411.5 F8W708 E7ERW0 ENST00000417466.5 C9JX59 ENST00000273038.7 E7EUJ2 ENST00000424529.6 [Q14135-5] ENST00000437722.1 C9JBN2 F8WBN7 Q0H0I7 Q0H0I4 ENST00000458499.5 ENST00000413604.5 ENST00000451674.6 [Q14135-6] A0A096LP98 E7EQU6 ENST00000426568.5 A0A075B6E4 ENST00000424709.5 E7EWF5 |